Logo CICANCER

Old CIC Events

Unexpected noncoding RNA roles in the regulation of the cancer genome 19/01/2023

Unexpected noncoding RNA roles in the regulation of the cancer genome

Maite Huarte — CIMA, University of Navarra

A new approach to old problems: epitranscriptomics in aging and rejuvenation 12/01/2023

A new approach to old problems: epitranscriptomics in aging and rejuvenation

Diana Guallar — Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidad de Santiago de Compostela

Emerging biomarkers for precision cancer medicine: Discovery, validation and clinical application 15/12/2022

Emerging biomarkers for precision cancer medicine: Discovery, validation and clinical application

Dr. Jian-Hua Mao — Lawrence Berkeley National Laboratory / University of California [Berkeley, USA]

Symposium on: Cancer genomics and epitranscriptomics: from the bench to the clinic 30/11/2022

Symposium on: Cancer genomics and epitranscriptomics: from the bench to the clinic

Tony Kouzarydes, Christina Curtis, Chuan He, Núria López-Bigas, Manel Esteller, Michaela Frye, Mathieu Lupien, Vessela Kristensen, Kamil R Kranc Barts, Cristian Bellodi, Donate Weghorn, Marco Gerlinger, Direna Alonso Curbelo, Óscar Rueda, Zohar Yakhini, José Seoane — https://symposiumcic2022.usal.es/

Defensa de la tesis doctoral "VRK1 functions in the DNA damage and oxidative stress responses and its implication in novel cancer therapies" 25/11/2022

Defensa de la tesis doctoral "VRK1 functions in the DNA damage and oxidative stress responses and its implication in novel cancer therapies"

Elena Navarro Carrasco — Programa de doctorado Biociencias: Biología y Clínica del Cáncer y Medicina Traslacional

Hyaluronic acid is a master regulator of tumor stroma 24/11/2022

Hyaluronic acid is a master regulator of tumor stroma

Juan Rodríguez Vita — Centro de Investigación Príncipe Felipe, Valencia [Spain]

Diversity of Quaternary Structures Regulates Nuclear Receptor Activities in Health and Disease 17/11/2022

Diversity of Quaternary Structures Regulates Nuclear Receptor Activities in Health and Disease

Eva Estébanez-Perpiñá — Institute of Biomedicine of the University of Barcelona (IBUB)

Defensa de tesis: Estudio del potencial terapéutico de la herramienta de edición genómica CRISPR/Cas9 en la Leucemia Mieloide Crónica 11/11/2022

Defensa de tesis: Estudio del potencial terapéutico de la herramienta de edición genómica CRISPR/Cas9 en la Leucemia Mieloide Crónica

Elena Vuelta Ramos — Programa de doctorado Biociencias: Biología y Clínica del Cáncer y Medicina Traslacional

Targeted protein degradation: drug discovery opportunities & resistance mechanisms 10/11/2022

Targeted protein degradation: drug discovery opportunities & resistance mechanisms

Cristina Mayor-Ruiz — Institute for Research in Biomedicine (IRB Barcelona)

Targeting KRAS: Light at the End of the Tunnel 27/10/2022

Targeting KRAS: Light at the End of the Tunnel

Mariano Barbacid — Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.

VRK1 functions in the DNA damage and oxidative stress responses and its implication in novel cancer therapies 21/10/2022

VRK1 functions in the DNA damage and oxidative stress responses and its implication in novel cancer therapies

Elena Navarro Carrasco — Centro de Investigación del Cáncer- IBMCC, Salamanca

RasGRF2 as a key regulator of cone photoreceptor function. 13/10/2022

RasGRF2 as a key regulator of cone photoreceptor function.

Alberto Fernández Medarde — Centro de Investigación del Cáncer (IBMCC, USAL-CSIC), Salamanca